Patents by Inventor Adam A. A. Sulaiman

Adam A. A. Sulaiman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11472819
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: October 18, 2022
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. Isab, Adam A. A. Sulaiman
  • Patent number: 11459343
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: October 4, 2022
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. Isab, Adam A. A. Sulaiman
  • Patent number: 11453684
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Grant
    Filed: January 27, 2020
    Date of Patent: September 27, 2022
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. Isab, Adam A. A. Sulaiman
  • Publication number: 20200299313
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. ISAB, Adam A. A. SULAIMAN
  • Publication number: 20200299312
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. ISAB, Adam A. A. SULAIMAN
  • Publication number: 20200299311
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Application
    Filed: January 27, 2020
    Publication date: September 24, 2020
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. ISAB, Adam A.A. SULAIMAN
  • Patent number: 10544165
    Abstract: The invention is directed to a method of treatment of proliferative diseases or disorders such as cancer with gold(I) N-heterocyclic carbene (NHC) thiourea or substituted thiourea complexes, to the complexes per se and to therapeutic compositions containing these gold(I) based complexes.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: January 28, 2020
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. Isab, Adam A. A. Sulaiman
  • Patent number: 10533029
    Abstract: Platinum(II) complexes with various selenones (L) having the general formula PtL2(NH3)2+2 X?2 are disclosed. The platinum(II) complexes inhibit growth of cancer cells in vitro and are useful for treatment of proliferative disorders such as cancers and/or tumors.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: January 14, 2020
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Anvarhusein A. Isab, Adam A. A. Sulaiman, Ali Alhoshani, Muhammad Altaf
  • Patent number: 10507213
    Abstract: Gold(I)-carbene complexes having a selenium donor ligand with anti-cancer activity and a method of treating cancer. Methods of treating cancer comprising administering the complexes are also provided.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: December 17, 2019
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Adam A. A. Sulaiman, Mohammad Altaf, Anvarhusein A. Isab
  • Publication number: 20190125757
    Abstract: Gold(I)-carbene complexes having a selenium donor ligand with anti-cancer activity and a method of treating cancer. Methods of treating cancer comprising administering the complexes are also provided.
    Type: Application
    Filed: October 26, 2017
    Publication date: May 2, 2019
    Applicant: King Fahd University of Petroleum and Minerals
    Inventors: Adam A. A. Sulaiman, Mohammad Altaf, Anvarhusein A. Isab
  • Patent number: 10189865
    Abstract: Gold(I) complexes as antiproliferative or antitumor agents. The gold(I) ion is connected to a N-heterocyclic carbene and further coordinated to a selone ligand. Also described are a pharmaceutical composition incorporating the gold(I) complex, a method of synthesizing the gold(I) complex, and a method for treating a proliferative disorder (e.g.
    Type: Grant
    Filed: January 8, 2018
    Date of Patent: January 29, 2019
    Assignee: King Fahd University of Petroleum and Minerals
    Inventors: Adam A. A. Sulaiman, Muhammad Altaf, Anvarhusein A. Isab